U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. OCE Publications
  1. Oncology Center of Excellence

OCE Publications

Journal publications by FDA oncology/hematology reviewers

Image
OCE Publications

The Oncology Center of Excellence supports a robust publications program that assists FDA oncology/hematology staff with manuscripts for publication in leading peer-reviewed scientific journals.

Oncology reviewers from the Office of Oncologic Diseases, working with clinical pharmacology, toxicology, and statistical reviewers, write summaries of many cancer drug approvals. FDA oncology staff also develop research articles and perspectives on important topics in cancer drug development, often in collaboration with academic and regulatory experts outside the FDA and internationally. The OCE Communications Program supports authors with editing and publication services.

Open the sections below to browse publications.

Additional Information

Back to Top